Comparison of methods for assessing synergic antibiotic interactions

被引:95
作者
Mackay, ML [1 ]
Milne, K [1 ]
Gould, IM [1 ]
机构
[1] Aberdeen Royal Infirm, Dept Med Microbiol, Aberdeen AB25 2ZB, Scotland
关键词
synergic; antibiotic; chequerboards;
D O I
10.1016/S0924-8579(00)00149-7
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Twenty-five combined microtitre chequerboard/time kill curves were performed on ten isolates from patients with relapsing infection to assess the potential for combination therapy. The isolates were Burkholdevia cepacia, Staphylococcus aureus and Klebsiella pneumoniae. No antagonism (FIC index or FBC index > 4) was observed with any combination. Synergy by time kill curve (present in 21 combinations) was more often seen at 24 h than 2 or 5 h (P < 0.001). On comparing the mean of the FIC and FBC indices, there were significant differences in only four chequerboards (P < 0.05). The same checkerboard was repeated on 3 separate days to test reproducibility. There were no significant differences (P > 0.05). All combinations showing synergism by FBC index were synergic by FIC index. Synergy by FIC index predicted synergy by FBC index in 67%. All combinations showing synergism by FIC index were synergic by time kill at 24 h but there was poor correlation between synergy at 2 or 5 h and synergy by FIC index or FBC index. In conclusion combining time kill and chequerboard tests gives reproducible results and good correlation between FIC and FBC indices. FIC indices showing synergy were also predictive of synergy in time kill studies. For bactericidal combinations unlikely to be antagonistic, calculation of FIC index may be a good indicator of synergic bactericidal activity. (C) 2000 Published by Elsevier Science B.V. and International Society of Chemotherapy. All rights reserved.
引用
收藏
页码:125 / 129
页数:5
相关论文
共 18 条
[11]  
LORIAN V, 1908, ANTIBIOTICS LAB MED, P537
[12]   COMPARISON OF TECHNIQUES FOR MEASUREMENT OF INVITRO ANTIBIOTIC SYNERGISM [J].
NORDEN, CW ;
WENTZEL, H ;
KELETI, E .
JOURNAL OF INFECTIOUS DISEASES, 1979, 140 (04) :629-633
[13]   In vitro synergistic activities of tobramycin and selected beta-lactams against 75 gram-negative clinical isolates [J].
Owens, RC ;
Banevicius, MA ;
Nicolau, DP ;
Nightingale, CH ;
Quintiliani, R .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (11) :2586-2588
[14]   REPRODUCIBILITY OF THE MICRODILUTION CHECKERBOARD METHOD FOR ANTIBIOTIC SYNERGY [J].
RAND, KH ;
HOUCK, HJ ;
BROWN, P ;
BENNETT, D .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (03) :613-615
[15]   SYNERGY BETWEEN CARBENICILLIN AND AN AMINOGLYCOSIDE (GENTAMICIN OR TOBRAMYCIN) AGAINST PSEUDOMONAS-AERUGINOSA ISOLATED FROM PATIENTS WITH ENDOCARDITIS AND SENSITIVITY OF ISOLATES TO NORMAL HUMAN-SERUM [J].
REYES, MP ;
ELKHATIB, MR ;
BROWN, WJ ;
SMITH, F ;
LERNER, AM .
JOURNAL OF INFECTIOUS DISEASES, 1979, 140 (02) :192-202
[16]   Comparison of three different in vitro methods of detecting synergy: Time-kill, checkerboard, and E test [J].
White, RL ;
Burgess, DS ;
Manduru, M ;
Bosso, JA .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (08) :1914-1918
[17]  
WOOTTON M, 1995, J ANTIMICROB CHEMOTH, P569
[18]   INVITRO SYNERGY TESTING OF TRIPLE ANTIBIOTIC COMBINATIONS AGAINST STAPHYLOCOCCUS-EPIDERMIDIS ISOLATES FROM PATIENTS WITH ENDOCARDITIS [J].
YU, VL ;
ZURAVLEFF, JJ ;
BORNHOLM, J ;
ARCHER, G .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1984, 14 (04) :359-366